Artiva Biotherapeutics annual net profit margin
2022
2023
2024
Artiva Biotherapeutics Net Profit Margin Growth & History (ARTV)
Artiva Biotherapeutics's net profit margin was −26,045.02% for fiscal 2024.
View full Artiva Biotherapeutics company overviewArtiva Biotherapeutics annual net profit margin history
| Fiscal year | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| 2024 | 2024-12-31 | −26,045.02% | −25957.79 pp |
| 2023 | 2023-12-31 | −87.23% | +1149.35 pp |
| 2022 | 2022-12-31 | −1,236.58% | — |
Artiva Biotherapeutics quarterly net profit margin
Q2.23
Q3.23
Q1.24
| Fiscal quarter | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| Q1 2024 | 2024-03-31 | −5,562.95% | — |
| Q3 2023 | 2023-09-30 | 42.31% | — |
| Q2 2023 | 2023-06-30 | −322.68% | — |
Artiva Biotherapeutics net profit margin trends
Between the periods ended 2022-12-31 and 2024-12-31, Artiva Biotherapeutics's net profit margin decreased from −1,236.58% to −26,045.02%, a change of −24808.44 percentage points. The latest reported quarter, Q1 2024, shows −5,562.95%.
About the metric
What net profit margin means
Net profit margin measures the percentage of revenue remaining as net income after operating costs, interest, taxes, and other expenses. It shows how much bottom-line profit or loss a company generates from each dollar of revenue.
Calculation and source
How net profit margin is calculated
TickerStat calculates net profit margin as SEC-reported net income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Artiva Biotherapeutics source filings ↗